Potential Risk Factors for Nivolumab-Induced Thyroid Dysfunction

In Vivo - Greece
doi 10.21873/invivo.11195
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

International Institute of Anticancer Research

Related search

Nivolumab Induced Thyroid Dysfunction: Unusual Clinical Presentation and Challenging Diagnosis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Risk-Based Screening for Thyroid Dysfunction During Pregnancy

Journal of Pregnancy
GynecologyObstetrics
2013English

Amiodarone-Associated Thyroid Dysfunction : Risk Factors in Adults With Congenital Heart Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

A Case of Nivolumab-Induced Severe Neutropenia With Stomatitis, Enteritis and Liver Dysfunction

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2018English

Retrospective Study of Risk Factors Associated With Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2018English

Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C

Korean Journal of Internal Medicine
Internal Medicine
2015English

Towards an Animal Model of Amiodarone-Induced Thyroid Dysfunction

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1997English

Review of Pathophysiological Aspects and Risk Factors for Liver Dysfunction

Archives of Clinical Gastroenterology
2016English

Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy